(NASDAQ: PROK) Prokidney's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 36.37%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.39%.
Prokidney's earnings in 2025 is -$72,474,000.On average, 8 Wall Street analysts forecast PROK's earnings for 2025 to be -$151,879,178, with the lowest PROK earnings forecast at -$181,689,991, and the highest PROK earnings forecast at -$135,958,497. On average, 8 Wall Street analysts forecast PROK's earnings for 2026 to be -$155,233,998, with the lowest PROK earnings forecast at -$216,297,609, and the highest PROK earnings forecast at -$117,418,702.
In 2027, PROK is forecast to generate -$133,633,666 in earnings, with the lowest earnings forecast at -$196,109,832 and the highest earnings forecast at -$52,529,419.